SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-005301
Filing Date
2020-01-10
Accepted
2020-01-10 13:59:34
Documents
3
Period of Report
2020-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d853039d8k.htm 8-K 24700
2 EX-99.1 d853039dex991.htm EX-99.1 13093
3 GRAPHIC g853039g28l15.jpg GRAPHIC 6940
  Complete submission text file 0001193125-20-005301.txt   48717
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 20520506
SIC: 2834 Pharmaceutical Preparations